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Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a hyper-inflammatory clinical syndrome associated with neoplastic disorders
especially lymphoma, autoimmune conditions, and infectious agents including bacteria, viruses, protozoa and fungi. In both
human and veterinary medicine, hemophagocytic histiocytic disorders are clinically important and frequently fatal. HLH in
humans can be a primary (familial, autosomal recessive) or secondary (acquired) condition, with both types generally
precipitated by an infectious agent. Previously, no mouse model for secondary HLH has been reported. Using Salmonella
enterica serotype Typhimurium by oral gavage to mimic naturally-occurring infection in Sv129S6 mice, we characterized the
clinical, hematologic and morphologic host responses to disease thereby describing an animal model with the clinico-
pathologic features of secondary HLH as set forth by the Histiocyte Society: fever, splenomegaly, cytopenias (anemia,
thrombocytopenia), hemophagocytosis in bone marrow and spleen, hyperferritinemia, and hypofibrinogenemia. Disease
severity correlates with high splenic and hepatic bacterial load, and we show disease course can be monitored and tracked
in live animals. Whereby secondary HLH is known to occur in human patients with typhoid fever and other infectious
diseases, our characterization of a viable natural disease model of secondary HLH offers an important means to elucidate
pathogenesis of poorly understood mechanisms of secondary HLH and investigation of novel therapies. We characterize
previously unreported secondary HLH in a chronic mouse model of typhoid fever, and novel changes in hematology
including decreased tissue ferric iron storage that differs from classically described anemia of chronic disease. Our studies
demonstrate S. Typhimurium infection of mice is a natural infectious disease model of secondary HLH that may have utility
for elucidating disease pathogenesis and developing novel therapies.
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Introduction
Hemophagocytic lymphohistiocytosis (HLH), an inflammatory
syndrome characterized by over-activation of macrophages and T
lymphocytes, can be triggered by diverse eukaryotic, bacterial
(especially intracellular), and viral pathogens [1–5]. HLH
mortality rates can reach 50–90% in part due to late recognition
and delayed onset of treatment [1,4]. Patients with clinico-patho-
logical characteristics of HLH are given differential diagnoses
that include Macrophage Activation Syndrome, Hemophagocytic
Histiocytosis, and Hemophagocytic Syndrome. The Histiocyte
Society has endeavored to improve clinical recognition and resolve
nomenclature issues by establishing a standard for HLH diagnostic
criteria [5]. Veterinary literature has reflected similarly variable
nomenclature for animals with hemophagocytic histiocytic disor-
ders [6–10]. Regardless of primary diagnosis, the 2004 HLH
diagnostic criteria require a patient have five of eight character-
istics: hemophagocytic macrophages in bone marrow, spleen,
and/or lymph nodes; two of three cytopenias (anemia, neutrope-
nia, and/or thrombocytopenia); splenomegaly; hyperferritinemia;
hypertriglyceridemia and/or hypofibrinogenemia; fever; high
soluble CD25; and low natural killer (NK) cell activity [5].
HLH can be primary (familial, fHLH) or secondary (sHLH).
Familial HLH is autosomal recessive, typically diagnosed in infants
or children, fatal if untreated [2,4], and generally precipitated by
infectious disease [3,5,11]. Thirty to seventy percent of fHLH
cases are associated with genetic mutations that cause NK and/or
CD8
+ T cell defects [5]. Four fHLH mouse models have been
described [12–15]; three have spontaneous or genetically engi-
neered mutations in Prf1, Unc13d or Rab27a, and fHLH is
triggered by viral infection. A fourth model is in mice deficient for
asparaginyl endopeptidase (AEP, legumain) [15]. In summary,
current mouse models of HLH involve genetic lesions and are
models of fHLH.
Secondary HLH occurs in all age groups and is associated with
infections across classes, malignancies especially lymphoma [1,3],
and autoimmune disorders, absent any known underlying genetic
defect [2]. HLH often has a nonspecific clinical presentation, and
although pathophysiologically distinct, is difficult to clinically
differentiate from sepsis [1,2,16], underlining the clinical impor-
tance of the Histiocyte Society’s diagnostic criteria [5]. Difficulty
in quantifying prevalence of sHLH is partly due to the diversity of
underlying primary diseases, and evidence suggests it is likely
under-diagnosed [2,4,17]. A fatality rate of 40% is reported for
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Standardized diagnostic criteria should continue to improve
recognition and yield more accurate prevalence statistics [5].
There are no reported mouse models of sHLH.
Data herein demonstrate that Salmonella enterica serotype
Typhimurium (S. Typhimurium)-infected mice have clinico-
pathological features of sHLH. Laboratory mice infected with S.
Typhimurium model human typhoid fever which is caused by
Salmonella enterica serovars Typhi and Paratyphi A, B and C [18].
Bacteria establish a chronic systemic infection in macrophages of
Peyer’s patches, mesenteric lymph nodes (MLN), spleen, liver
and gall bladder [19–21]. Much of S. Typhimurium research has
focused on fatal acute infections in mice compromised for innate
immunity, generally Balb/c, C57BL/6, or DBA/1 strains, which
are Slc11a1/Nramp1
2/2 [22,23]. However, in immunocompe-
tent mice (Sv129S6, Slc11a1/Nramp1
+/+) S.T y p h i m u r i u m
causes persistent systemic infection that most mice survive [19].
Both murine and human typhoid fever can result in a subcli-
nical chronic carrier state [18,21]. Bacteria are found with-
in macrophages during both acute and chronic infection
[19,24,25], and cytokines including IL-1b and IL-18 are
produced during pro-inflammatory caspase-1 dependent pro-
grammed cell death (pyroptosis) [26]. Hemophagocytic macro-
phages are a feature of both human typhoid fever [27–30] and
HLH [5]. Importantly, S. Typhimurium replicates preferentially
within cultured hemophagocytic macrophages in the Sv129S6
mouse model [24]. Here we demonstrate that Sv129S6 mice
infected with S. Typhimurium acquire the clinico-pathological
characteristics of HLH (Table 1), thus establishing an animal
model for sHLH.
Results
Our findings of neurological disease, splenomegaly and
inflammatory lesions are consistent with prior descriptions of
murine S. Typhimurium infection [18,19,24,25,31–33,21]. Addi-
tionally, we describe detailed hematopoietic responses over the
course of infection that characterize a) a non-lethal method to
monitor S. Typhimurium infection via complete blood count
(CBC), b) features of a secondary HLH syndrome, and c)
responsive hematopoiesis with alterations in body iron that differ
from anemia of inflammatory (or chronic) disease (ACD).
Hematology and clinico-pathologic findings in S. Typhimurium-
infected Sv129S6 mice are summarized in Figure 1 (16-week
study), and Tables 1 and 2 (10-week study).
Clinical and Hematological Findings
Fever and neuropathy. Infected mice developed slight fevers
and clinical neurological signs including ataxia, head tilt, uni-
directional circling when ambulating, and uni-directional rotatory
spinning when lifted by the tail in seven of twenty-one mice
(Table 1), and two of eight mice (16-week study). Mice with the
most severe neurological signs failed to gain weight and accounted
for the single early death in each study. While only fever is a
formalized diagnostic criterion for HLH, both fever and
neurological disease are common to HLH [1,3,2,34].
Inflammatory leukogram. Hematological findings included
acute and ongoing response to infection characterized by imme-
diate onset of neutrophilia (Figure 1A; Table 2) and later onset (3–
5 weeks post-infection) of monocytosis (Figure 1B; Table 2).
Rare band neutrophils were also seen. Lymphopenia (Figure 1C;
Table 1. Clinico-pathologic features of HLH in S. Typhimurium-infected mice.
One-week PI Three-weeks PI Six-weeks PI Ten-weeks PI
{Increased hemophagocytic macrophages
(bone marrow and/or spleen)
5/6 mice 4/6 mice 6/7 mice 2/2 mice
{Fever Days 17–23*
{Splenomegaly, % of body weight: median (range),
fold difference from C
2X* (2-3X)
6/6 mice
3X (1-14X)
5/6 mice; 10/10 mice
{
3X* (1-5X)
6/7 mice
3X (1-3X)
1/2 mice
{Cytopenias:
thrombocytopenia
C range =9.2–10.5610
5/mL
anemia
C range =53–55 (HCT%)
2/6 mice
(7.7–11.1)
1/6 mice*
(48–53)
5/6 mice*
(0.9–9.8)
2/6 mice
(29–53)
3/6 mice*
(5.0–9.3)
0/6 mice
(51–56)
0/2 mice
(10.6–10.7)
0/2 mice
(51–55)
{Hypofibrinogenemia
C range (200–400 mg/dl)
0/6 mice 2/6 mice
(100)
2/6 mice
(100)
0/6 mice
{Hyperferritinemia
C range (699–1260 mg/L)
No 2/6 mice;
3/10 mice
{
(1425–6140)
No No
Range CFU/g: spleen 10
2–10
4 10
4–10
5 10
3–10
4 10
1–10
2
liver 10
2–10
4 10
3–10
4 10
2–10
3 None detected
1Clinical neurological signs 7/21 mice- onset
Day 5–12
6/21 mice – signs
gone by Day 18
1/21 mice- early
death Day 37
None
PChronic active hepatitis Acute hepatitis
5/6 mice
Chronic active
hepatitis 5/6 mice
Chronic active
hepatitis 7/7 mice
Chronic active
hepatitis 1/2 mice
PI indicates post-oral infection with 2.0610
9 CFU Salmonella enterica serotype Typhimurium; C indicates mock-infected control mice.
*P,0.05, Student’s t-Test.
{Independent experiment, same bacterial dosing and range for splenic bacterial CFU results.
{Formal diagnostic criteria for HLH per the Histiocyte Society guidelines [5].
1Consistent with a diagnosis of HLH, and
P strong supportive evidence for HLH [5].
doi:10.1371/journal.pone.0009441.t001
Mouse Model of Secondary HLH
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disease and/or tissue infiltration by lymphocytes [1,35]. Up to
30% of lymphocytes had vacuolated cytoplasm. Thus, an acute
inflammatory response transitioning to chronic active inflamma-
tion was demonstrated.
Responsive microcytic anemia. Infected mice had early
onset slight to moderate microcytic anemia which was most severe
at three weeks post-infection, correlating with highest bacterial
tissue loads and most severe splenomegaly (Figure 1D–E; Table 2).
Even after hematocrits (HCT) had recovered, microcytosis of
erythrocytes (Figures 1D–E; Table 2) and reticulocytes (Table 2)
persisted (demonstrated as decreased mean cell volume, MCV
and MCVR, respectively). A marked regenerative erythroid res-
ponse, measured by increased reticulocyte counts, polychromasia
(Tables 1–2; Figure 2F) and red cell distribution widths (RDW)
(Table 2), was present in highly infected mice. Reticulocytes were
hypochromic (decreased CHr) at all time points (Table 2). These
changes occurred together with hypoferremia in all but one
infected mouse at three weeks post-infection; this mouse had an
appropriate macrocytic regenerative response consistent with its
normal serum iron concentration (Table 2). Erythrocytosis, which
can occur with microcytic anemia [36,37], was present from weeks
6–10 (Table 2, 10-week study), and 5 – 14 (P,0.05; 16-week
study). Increased RDW at week six (Table 2) and weeks 3–14
(P,0.05; 16-week study) demonstrated erythrocyte anisocytosis.
Blood film review confirmed erythrocyte anisocytosis, micro-
cytosis and polychromasia (Figure 2E–F). Marked fragmentation
(schistocytes) of mature and polychromatophilic erythrocytes (10–
12% of cells affected) occurred at three weeks in highly infected
mice (Figure 2F). Schistocytes were rare (,1%) at six weeks,
and absent at 10 weeks post-infection. These data represent re-
generative microcytic anemia and altered body iron status in
highly infected mice.
Thrombocytopenia. Thrombocytopenia present from weeks
1–10 (Tables 1, 2) was most severe in highly infected mice at three
weeks post-infection. Increased mean platelet volume (MPV)
(Table 2) indicated increased thrombopoiesis in response to
thrombocytopenia [35], and circulating macro-platelets were
confirmed by blood film review; increased MPV was also pre-
sent at weeks 1–11 (P,0.05) in the 16-week study (data not
shown). Thus, S. Typhimurium infection in live animals can be
monitored by CBC, and bi-cytopenia (anemia and thrombocy-
topenia), characteristic for HLH [5], was demonstrated in highly
infected mice.
Bacterial Tissue Loads and Splenomegaly
Serum IgG titers to Salmonella O-Antigen, measured in the 16-
week study, were 100–1,000 fold higher than mock-infected
control from weeks 5–16 post-infection (data not shown). At 16-
weeks post-infection, there was no recoverable S. Typhimurium in
cecum, MLN, liver or spleen in five of eight mice, including two of
five mice with high serum IgG. In the 10-week experiment
(Table 1), bacterial colony forming units per gram (CFU/g) of liver
and spleen was greatest at three weeks post-infection, consistent
with the time-point of most severe HLH pathology (Tables 1–2),
and decreased by six and 10 weeks post-infection.
Splenomegaly was present in six of seven infected mice at the
conclusion of the 16-week study (P,0.05). Hepatosplenomegaly
occurred at all time points in S. Typhimurium-infected mice in the
10-week study (Table 1). By comparison, livers of infected mice
were 1.2 to 1.6 fold larger (median weight compared to body
weight) than mock-infected controls overall (P,0.05 at one and
three weeks post-infection). Mice with the highest splenic bacterial
loads (10
5 CFU/g at three weeks post-infection) had the largest
Figure 1. Hematology of S. Typhimurium-infected mice: acute,
then chronic active inflammatory response; microcytic anemia,
persistent microcytosis. Mice were orally gavaged with 9.1610
8 CFU
of S. Typhimurium (n=8) or sterile PBS (n=7). Complete blood counts
were monitored over 16 weeks. X = S. Typhimurium-infected mice;
circle = mock-infected control mice. Mean and standard deviation are
shown. (A) neutrophils, (B) monocytes, (C) lymphocytes, (D) hematocrit
(HCT), (E) mean cell volume (MCV). *P,0.05 (Student’s t-test).
doi:10.1371/journal.pone.0009441.g001
Mouse Model of Secondary HLH
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4 CFU/g)
and largest livers. An inverse correlation occurred between spleen
weight, and HCT and platelet counts; infected mice with the
greatest degree of splenomegaly had the lowest HCT and platelet
counts. Importantly, splenomegaly persisted beyond the presence
of measurable CFU of S. Typhimurium, and splenic bacterial load
and splenomegaly correlated with the most severe cytopenias.
Bone Marrow Cytopathology, Tissue Histopathology and
Iron Studies (10-Week Experiment)
Bone marrow myeloid hyperplasia and splenic extrame-
dullary hematopoiesis (EMH). Bone marrows were hyper-
cellular (Figure 2C), and increased splenic erythroid, myeloid and
megakaryocytic EMH (Figure 3B) was observed at all time points
post-infection, consistent with inflammation and murine respon-
sive hematopoiesis [35,38]. While erythroid elements were
present, bone marrow hypercellularity was primarily due to in-
creased granulopoiesis (myeloid hyperplasia) with increased num-
bers of blasts (myeloblasts and monoblasts), monocytes and
morphologically benign histiocytes (Figure 2A–B). Increased
numbers of blasts in the bone marrow at three weeks post-
infection (maturation left shift) were characteristic for accelerated
production of granulocytic and/or monocytic precursors in
response to ongoing infection (Figure 2B). While differentiating
myeloblasts from monoblasts by morphology alone on review of
bone marrow cytology is difficult [39], a corresponding increase in
blood monocyte counts (Table 2) indicated that a proportion of the
blasts were of monocytic origin. Increased granulocytic and
monocytic ring forms in bone marrow and blood films (not shown)
were consistent with accelerated hematopoiesis in mice [35,39].
These findings correlate with the CBC results of neutrophilia and
monocytosis, with ongoing inflammatory disease and neutrophil
recruitment to tissues (Table 2; Figure 3A–B), and increased
splenic EMH (Figure 3B).
To further evaluate erythropoiesis, enlarged spleens from
Salmonella-infected mice were analyzed by flow cytometry three
weeks after infection. Results from three replicate experiments
showed increased numbers of erythroblasts compared to controls
Table 2. Hematologic parameters of S. Typhimurium-infected mice.
Parameter Week 1 Week 3 Week 6 Week 10
C, n=4 I, n=6 C, n=4 I, n=6 C, n=3 I, n=6 C, n=1 I, n=2
WBC610
3/ml 5.73
+1.61
5.32
+1.82
7.23
+1.93
5.32
+2.01
7.03
+1.62
8.13
+1.99
6.8 14.8,
6.7
RBC610
6/ml 9.79
+0.37
9.70
+0.25
9.79
+0.31
9.20
+1.83
9.64
+0.32
11.42*
+0.25
8.86 11.43,
9.42
Neutrophils
x10
3/ml
0.50
+0.20
1.35*
+0.61
0.75
+0.21
1.25*
+0.43
0.63
+0.23
1.82*
+0.63
0.40 4.00,
0.60
Monocytes
x10
3/ml
0.07
+0.06
0.17
+0.10
0.10
+0
0.23*
+0.05
0.10
+0
0.43*
+0.10
0.10 0.50,
0.10
Lymphocytes
x10
3/ml
4.73
+1.34
3.57
+1.84
6.28
+1.37
3.72
+2.24
6.00
+1.68
5.70
+2.02
6.10 10.10,
5.80
HCT, % 53
+0.6
51*
+1.6
53
+1.7
46
+11.3
53
+1.2
54
+1.8
51 55,
51
MCV, fl 54.0
+2.0
52.0
+0.9
54.3
+1.3
49.7
+4.8
55.7
+1.5
47.3*
+1.0
58.0 48.0,
54.0
MCVr, fl 59.3
+1.5
56.3
+3.1
59.3
+0.5
52.8*
+5.4
62.0
+1.0
55.8*
+1.7
62.0 59.0,
63.0
MCHC, g/dl 31.0
+0
31.5
+0.5
31.3
+0.5
30.0
+1.8
30.0
+1.0
30.0
+0.6
30.0 30.0,
31.0
RDW 12.4
+0.4
12.7
+0.2
12.5
+0.2
16.7
+4.9
12.7
+0.1
14.6*
+1.5
12.6 14.3,
13.0
Platelets
x10
6/ml
1.02
+0.03
1.00
+0.14
0.92
+0.06
0.54*
+0.33
1.05
+0.06
0.79*
+0.16
0.87 1.06,
1.07
MPV, fl 7.3
+0.3
7.1
+0.2
7.3
+0.3
7.2
+1.0
7.7
+0.2
8.2
+0.6
6.7 7.1,
6.7
Reticulocytes
x10
6/ml
0.48
+0.07
0.41
+0.18
0.40
+0.07
0.71
+0.40
0.44
+0.03
0.41
+0.06
0.57 0.54,
0.64
CHr, pg 17.9
+0.4
16.7*
+1.0
17.7
+0.1
15.0*
+2.3
17.4
+0.2
15.5*
+0.4
17.4 15.8
17.8
Serum Iron mg/dl 262
+10
297
+124
267
+26
219
+89
269
+30
266
+40
222 202,
280
Twenty-one mice were orally gavaged with 2.0610
9 CFU of S. Typhimurium (I) and 13 mice with sterile PBS as mock-infected controls (C). No hematological data were
obtained from one early death mouse. Complete blood counts (CBC) and serum iron were measured at weeks 1, 3, 6, and 10 post-infection. Data presented as mean +1
standard deviation, except 10 weeks where data from all mice shown.
WBC indicates white blood cells; RBC, red blood cells; HCT, hematocrit; MCV, mean cell volume; MCVr, mean cell volume reticulocytes; MCHC, mean cell hemoglobin
concentration; RDW, red cell distribution width; MPV, mean platelet volume; and CHr, mean cell hemoglobin reticulocytes.
*P,0.05, Student’s t-Test.
doi:10.1371/journal.pone.0009441.t002
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increased splenic erythropoiesis was substantiated and quantified
by flow cytometric analysis. Bone marrow and splenic pathology in
S. Typhimurium-infected mice indicated accelerated hematopoi-
esis in response to active and ongoing inflammatory disease,
anemia and thrombocytopenia.
Bone marrow hemophagocytic macrophages. Increased
numbers of hemophagocytic macrophages in the bone marrow or
spleen are consistent with HLH [5] (Table 1). Review of bone
marrow films demonstrated increased hemophagocytic macro-
phages in mice at all time points post-infection (Table 1;
Figure 2B,D), from occasional (1–3/slide) to numerous (1/1–2
Figure 2. S. Typhimurium-infected mice have increased hemophagocytic macrophages, myeloid hyperplasia, regenerative
microcytic anemia and erythrocyte fragmentation. (A) Control bone marrow cytology, 3 weeks post mock-infection. (B) Infected mouse bone
marrow cytology, 3 weeks post-infection; myeloid hyperplasia with increased blasts and monocytes, hemophagocytic macrophage (white arrow), and
foamy macrophage (black arrow). (C) Bone marrow histology, 6 weeks post-infection; hypercellularity with myeloid hyperplasia. (D) Mouse bone
marrow cytology, 3 weeks post-infection; erythrocyte (arrow and inset) within hemophagocytic macrophage. (E) Control mouse blood film, 3 weeks
post mock-infection. (F) Blood film from highly infected mouse, 3 weeks post-infection; marked erythrocyte anisocytosis, increased polychromasia
and markedly fragmented erythrocytes (mature and polychromatophilic). Polychromatophilic erythrocytes (arrow-heads), fragmented polychro-
matophilic erythrocytes (carats), fragmented erythrocytes (arrows), L=small lymphocyte. Wright stain (A, B, D, E, F). H & E stain (C). Original
magnifications 5006(A–B, D), 2006(C), or 10006(E–F).
doi:10.1371/journal.pone.0009441.g002
Mouse Model of Secondary HLH
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iron. (A) Mouse liver, 6 weeks post-infection; inflammation and necrosis (arrow). (B) Mouse spleen, 3 weeks post-infection; extramedullary
hematopoiesis (EMH; arrow, megakaryocytes), histiocytic infiltration (I) throughout the red pulp, and thrombus (T). H&E stain (A, B). (C) Spleen, mock-
infected(left)andinfectedmouse(right), 3weekspost-infection; markedlydecreasedferricironstaininginredpulp.(D)Spleen,mock-infected(left)and
infected mouse (right), 6 weeks post-infection; markedly decreased splenic ferric iron in red pulp. Perl’s Prussian Blue stain (C, D). (E) Hemophagocytic
macrophage in mouse spleen 3 weeks post-infection that had 10-fold more macrophages and 43-fold more 6N+ macrophages than control mouse
spleen. CD11b (red), DAPI(blue), TER119 (green). N = endogenous macrophagenucleus, E1 = nucleated erythrocyte, E2 = non-nucleated erythrocyte.
Confocal fluorescent micrograph. (F) Representative histogram overlay of TER119 expression on DAPI+ splenocytes from a mock-infected (red) and
infected mouse (blue) 3 weeks post-infection. Filled gray histogram corresponds to the isotype control. The infected mouse had 11.5-fold more
TER119
med pro-erythroblasts and 5.5-fold more TER119
high erythroblasts than the mock-infected mouse. (G) Mean numbers of TER119
med and
TER119
high splenocytes from three mock-infected (white bars) and four infected (gray bars) mice. Mean number of TER119
med pro-erythroblasts per
spleen increased 6.8-fold in infected mice, while the mean number of TER119
high cells, corresponding to all nucleated erythroblasts subsequent to the
pro-erythroblast stage [40], increased 3.6-fold. (P,0.05) Error bars=SD. Original magnifications 1006(A–B), 2006(C–D), and 10006(E).
doi:10.1371/journal.pone.0009441.g003
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slide). Finding two hemophagocytic macrophages per slide is
considered significant when reviewing bone marrow cytology
for human HLH [28]. Increased hemophagocytosis, present in
spleens of infected mice examined by histopathology, was also
demonstrated by confocal microscopy via TER119 staining of
nucleated and non-nucleated erythrocytes within the cytoplasm of
CD11b
high, GR1
low macrophages (Figure 3E). Consistent with
sHLH and typhoid fever [28,29], S. Typhimurium-infected mice
have increased numbers of hemophagocytic macrophages in bone
marrow and spleen.
Liver and spleen histopathology, thrombosis and hypo-
fibrinogenemia. Tissue inflammation and thrombosis
occurred in S. Typhimurium-infected mice. Acute multifocal to
coalescing neutrophilic hepatitis with necrosis was present at one
week post-infection. At subsequent time-points, chronic active
inflammation was characterized by multifocal to diffuse lympho-
histiocytic infiltration with a neutrophilic component, and
multifocal areas of hepatocellular necrosis (Figure 3A).
Continuous recruitment of neutrophils was evident in all
infected mice. Chronic active hepatitis, while not a formalized
diagnostic criterion for HLH, is consistent with the described
liver lesion in human HLH [5]. Splenic lesions included
multifocal histiocytic infiltration and hemophagocytosis, with
marked expansion of the red pulp by EMH and morphologically
benign histiocytes at all timepoints (Figure 3B). Lymphoid
follicular disruption with depletion of the white pulp was also
present (Figure 3B), particularly at six and 10 weeks post-
infection, consistent with a previously described change in mice
with marked EMH in response to anemia [36], and splenic
pathology in people with HLH [28]. Hepatic microthrombi were
present in two of six mice at one and six weeks post-infection,
while marked thrombosis was present in the spleen (Figure 3B)
and liver (not shown) in two of six mice at three weeks post-
infection. These findings correlated with plasma hypofi-
brinogenemia in the highly infected mice at three and six
weeks post-infection (Table 1). Marked splenic and hepatic
thrombosis also occurred in the early death mouse at six weeks
post-infection. Masson’s staining was negative for fibrosis in liver
and spleen sections atalltime points (notshown). Thus, persistent
hepatosplenomegaly as a result of ongoing inflammatory lesions
and EMH in the spleen was present in S.T y p h i m u r i u m - i n f e c t e d
mice, and tissue thrombosis correlated with hypofibrinogenemia,
an HLH diagnostic criterion [5].
Hyperferritinemia, hypoferremia, decreased tissue iron
staining. Serum iron was decreased at one (two of six mice)
and three (four of six mice) weeks (Table 2) post-infection
compared to control mice. Hyperferritinemia occurred in 2/6
and 3/10 mice in separate experiments at three weeks post-
infection (Table 1). Mice with splenic bacterial loads .10
5 CFU/
g and the largest degree of splenomegaly had the most marked
hyperferritinemia (.4,300 mg/L) (Table 1). By six weeks post-
infection serum ferritin and iron concentrations were similar to
controls although splenomegaly and erythrocyte microcytosis
persisted (Tables 1–2). Spleen was the predominant iron storage
organ in control mice at all time points where staining intensity
for ferric iron in the splenic red pulp (3C–D) was two to four-fold
greater than control livers, and four to eight-fold greater than
control bone marrows. This is consistent with spleen being the
major site for iron storage and EMH [35,33] compared to liver in
wild type, healthy mice. Overall, decreased tissue staining for
hemosiderin (ferric iron) occurred at all time points post-S.
Typhimurium-infection in mouse spleen (Figure 3C–D), liver and
bone marrow (not shown) compared to mock-infected control
mice. In addition, another feature of HLH, hyperferritinemia,
was demonstrated in mice with high tissue bacterial loads, and
significant changes in body iron status occurred post-infection
with S. Typhimurium.
To summarize results, evaluations of blood, bone marrow, liver
and spleen of S. Typhimurium-infected mice demonstrated active
and ongoing hematopoiesis, inflammatory disease, and six of eight
characteristics of sHLH in highly infected mice.
Discussion
Infection of Sv129S6 wild-type mice with S. Typhimurium via
the natural oral route precipitates, as expected [18,19], an acute
inflammatory response followed by subacute to chronic inflam-
matory disease. While the inflammatory response is consistent with
prior descriptions of murine typhoid fever [18,19,23,31], new to
this infectious disease model are clinico-pathologic features of
HLH (Table 1) demonstrated by increased hemophagocytic
macrophages in bone marrow and spleen, fever, hepatospleno-
megaly, bi-cytopenia (anemia, thrombocytopenia), hypofibrino-
genemia, and hyperferritinemia (.1400 mg/L). At three weeks
post-infection, the most severely infected mice with the highest
bacterial CFU/g of spleen meet six of eight of the HLH diagnostic
criteria, five of which are needed to diagnose HLH in humans [5].
These data substantiate a novel clinical mouse model for sHLH.
While a diagnosis of HLH cannot be solely based on finding
hemophagocytic macrophages, an increased number especially in
bone marrow cytology (Figures 2B,D) and spleen (Figure 3E) is a
classic characteristic of HLH [5,28], and also occurs with human
typhoid fever [3,28,29]. In a prior study demonstrating hemo-
phagocytic macrophages in livers of infected mice, S. Typhimur-
ium was shown to survive and replicate in tissue culture hemo-
phagocytic macrophages [24]. Erythrophagocytic macrophages
have been shown to express heme-oxygenase 1 (HO-1) in human
sepsis cases [41], and inhibit pro-inflammatory cytokine produc-
tion in cultured mouse bone marrow cells (Slc11a1/Nramp1
+/+)
[42], thereby suggesting an anti-inflammatory role. Increased
serum HO-1 also occurs in cases of sHLH in correlation with
hyperferritinemia [43]. Whether HO-1 facilitates S. Typhimurium
survival in hemophagocytic macrophages is unknown, however, a
plausible hypothesis is that intracellular bacterial access to iron
released during heme breakdown following erythrophagocytosis
provides S. Typhimurium with an essential survival nutrient. Thus,
hemophagocytic macrophages may provide a survival niche for S.
Typhimurium contributing to the subclinical chronic carrier state
important in people and mice with typhoid fever, as well as the
pathology of cytopenias, including anemia and thrombocytopenia,
in Salmonella-infected mice. Hemophagocytic macrophages may
have an anti-inflammatory effect, provide S. Typhimurium a
survival niche, and contribute to development of cytopenias,
all of which could help elucidate mechanisms of sHLH disease
pathogenesis in this natural infectious disease model.
Activated macrophages are integral to the development of HLH
[1,2]. Secretion of plasminogen activator by activated macro-
phages contributes to the coagulopathies that occur in HLH
[2,28]. Indeed, disseminated intravascular coagulation (DIC) has
been reported in humans with HLH [1,3,44] or typhoid fever [45],
and highly infected mice in our study had characteristics of DIC
including thrombocytopenia, (Figure 1; Tables 1–2) hypofibrino-
genemia, tissue thrombosis (Figure 3B), and schistocytes in the
blood (Figure 2F). In humans, severe hyperferritinemia in HLH
correlates with death [1] and is useful as a diagnostic marker for
HLH [4,5,43,44]. Serum ferritin levels are highest (.12,000 mg/
L) in human histiocytic disorders in which the patients also have
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in our studies had hyperferritinemia that was greatest (.4,300 mg/
L) in mice with most severe splenomegaly and splenic bacter-
ial CFU (Table 1). Hyperferritinemia has also been reported in
canine and feline histiocytic disorders [6,9], and in acute S.
Typhimurium infection in mice [23], and should alert both human
and veterinary clinicians to the possibility of hemophagocytic
histiocytic disorders. These observations collectively indicate
activated macrophages play a key role in the pathophysiology of
S. Typhimurium-induced sHLH.
The pathogenesis of bi-cytopenia in this mouse model is likely
multifactorial. Adequate to increased megakaryocytes in bone
marrow (Figure 2C) and spleen (Figure 3B) make lack of platelet
production an unlikely cause for thrombocytopenia. Platelet
sequestration within enlarged spleens may have contributed to
thrombocytopenia. Additionally, increased platelet destruction by
hemophagocytosis or platelet consumption from DIC [35] may
have occurred in highly infected mice (Table 1). Also, regardless of
bacterial tissue load, S. Typhimurium-infected mice developed
erythrocyte microcytosis, and highly infected mice developed a
regenerative microcytic anemia that differed from ACD by a
demonstrated lack of tissue iron sequestration [35,46] (Figure 3C–
D) even in mice with hyperferritinemia. Our findings of increased
erythropoiesis and hemophagocytosis differ from the non-regen-
erative anemia previously described in acute, fatal S. Typhimur-
ium infection in genetically susceptible mouse strains [23]. The
pathogenesis of microcytosis in S. Typhimurium-infected mice
in our studies may involve several mechanisms including iron
deficiency [37,47] or fragmentation of erythrocytes [48] known to
occur with both iron deficiency [37] and DIC. Erythrocyte
fragmentation was severe enough to decrease MCV only in highly
infected mice that also had evidence of DIC and low serum iron
concentration. Persistent microcytosis following recovery of
anemia and reduced tissue iron staining indicate iron stores were
mobilized to support erythropoiesis and/or sequestered in ferritin
as a result of increased heme breakdown by macrophages. As iron
stores were depleted, ongoing accelerated erythropoiesis could
have resulted in a progressive decrease in MCV as in iron
deficiency. Another hypothesis for persistent microcytosis is altered
iron metabolism. Changes in iron metabolism have been
demonstrated in response to acute S. Typhimurium infections in
susceptible strains of mice [23] and in tissue culture macro-
phages [49]. Functional iron deficiency may be a mechanism
for controlling infection by limiting microbial access to iron.
Decreased intracellular iron content of S. Typhimurium-infected
macrophages [49] is consistent with reduced tissue iron storage in
macrophages (Figure 3C–D) and differs from ACD. These findings
suggest iron was mobilized from tissues to support stimulated
erythropoiesis in the face of cytopenias, because of increased
ferritin synthesis, and alternatively, or in addition, there may have
been efflux of iron from macrophages presumably via the iron
exporter ferroportin to reduce intracellular S. Typhimurium
access to iron, a mechanism previously described [49]. Thus, the
hematologic effects and depleted tissue iron storage in chronic S.
Typhimurium-infected mice differentiate it from ACD and from
acute fatal murine salmonellosis, and this model provides an
opportunity to study mechanisms for anemia in HLH and altered
iron trafficking in response to infection with S. Typhimurium.
The mouse strain chosen for this study was important given the
effect of murine genetic variability on iron homeostasis [50],
hematology [23,35,38] and S. Typhimurium resistance [19,22].
Sv129S6 mice, intact for Slc11a1/Nramp1 which helps maintain
iron homeostasis via phagolysosomal transport of divalent cations
including iron [49], efficiently recycle erythrocyte-derived iron in
macrophages [51], and are resistant to S. Typhimurium infection
[19]. Indeed iron loading has been shown to increase susceptibility
to acute S. Typhimurium infection in mice [23], therefore, iron
deficiency may have contributed to increased bacterial resistance
in our studies. In addition, Sv129 mice are better able to maintain
iron homeostasis under conditions of both iron deficiency and
excess compared to other mouse strains including C57BL/6,
DBA/2 and CBA [50]. Wild type Sv129S6 mice have been shown
to mobilize liver iron stores in response to iron deficiency where
iron-limited erythropoiesis was maintained in the face of
developing microcytosis [47]. Therefore, this Sv129S6 infection
model may prove particularly useful in elucidating mechanisms of
anemia in HLH, and altered iron homeostasis and anemia during
chronic S. Typhimurium infection that are different from ACD.
Due to expansion of red pulp by EMH and inflammation,
splenomegaly persists in mice even after bacterial CFU have
cleared. Persistent splenomegaly also occurs in human HLH [2],
and in prior studies of S. Typhimurium-infected mice [19,31].
This mechanism may include persistence of bacterial antigen, for
instance on follicular dendritic cells and/or on MHC class II
molecules [22,52,53], that continues to drive cytokine production,
inflammation and increased EMH in response to anemia and
thrombocytopenia, resulting in persistent splenomegaly. Impor-
tantly, mice with the greatest magnitude of splenomegaly also had
the most severe cytopenias.
Approximately 30% of the mice in our studies developed
clinical neurological signs from which most recovered. The
incidence of neurological disease in HLH patients varies from
37% in children [34], to 7–47% for all patients [3]. Neurological
disease, while previously characterized in Slc11a1/Nramp1 wild
type mice orally infected with S. Typhimurium [32], is clearly
relevant to both HLH and typhoid fever, and may provide a
means to clinically monitor response to therapeutic interventions.
Abnormal lipid processing is known to occur with HLH
[5,28,54], and one of the diagnostic criteria for HLH is hyper-
triglyceridemia [5]. An effect on lipid processing in S. Typhimur-
ium-infected mice is suspected based on finding vacuolated
lymphocytes on blood films and foamy bone marrow macrophages
(Figure 2B), features that also occur with lipid storage diseases
[55,56]. Cytokine-mediated decreases in lipoprotein lipase have
been shown to occur with increased IFNc and TNFa in mice [57],
and TNFa in human fHLH patients [54]. In addition, a role for
lipid (via cholesterol esterification) in intracellular survival of S.
Typhimurium has been suggested [58]. A future direction for
understanding HLH pathophysiology in this model will be inve-
stigating altered lipid metabolism including lipoprotein lipase,
triglycerides, cholesterol and PGF2a analyses.
The important findings in highly infected mice in this chronic
systemic infection model are those demonstrating first, an HLH
syndrome and second, anemia different from ACD and acute
murine S. Typhimurium infection. To understand how HLH
develops and can be ameliorated, it is necessary to understand the
molecular and cellular events that can precipitate HLH. A viable
animal model is critical to understanding pathogenesis and for
intervention strategies. Thus, future directions for this mouse
model include cytokine profiling and characterization of specific
lipid and iron cellular markers and metabolism. A further
understanding of the unique pathologies of increased hemopha-
gocytosis, hyperferritinemia and inflammatory disease without
tissue iron loading, in the face of microcytic anemia may help
elucidate pathophysiology of anemia in HLH that differs from
ACD. Features of S. Typhimurium-infected mice that substantiate
its value as an sHLH animal model include a natural host-
pathogen interaction, no known single-locus genetic component,
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and infectious agent, and a tissue-load dependent and manipulable
model. S. Typhimurium-infected mice have the features of sHLH
yet have a low mortality rate (approximately 7%) even without
treatment intervention. This provides a viable model to study
sHLH pathogenesis over time, and novel targets for HLH
therapies and therapeutic response by clinical, hematological,
immunological, pathological and molecular means.
Materials and Methods
Ethics Statement
Research protocols were in accordance with the NIH Guide for
the Care and Use of Laboratory Animals, and approved by the
University of Colorado Institutional Biosafety and Animal Care
and Use Committees.
To characterize hematological responses and establish clinico-
pathologic features of HLH in S. Typhimurium-infected mice,
two studies of 16 and 10 weeks duration, respectively, were
undertaken. Specific HLH diagnostic criteria [5] analyzed
included hemophagocytic macrophages in bone marrow and
s p l e e n ,f e v e r ,s p l e n o m e g a l y ,c y t o p e n i a s ,p l a s m af i b r i n o g e n ,a n d
serum ferritin.
Bacteria and Mice
Freshly struck colonies of virulent Salmonella enterica serotype
Typhimurium strain SL1344 (StrR) [24,59], inoculated into
Luria-Bertani broth were grown at 37uC with aeration overnight.
Bacteria were pelleted and resuspended in sterile PBS at 9.1610
8
–2 . 0 610
9 CFU in 100 mL, as determined by plating. Strepto-
mycin (200 mg/mL) was added to media to select for S.
Typhimurium. Female seven week-old Sv129S6/SvEvTac mice
(Taconic Farms, Inc.; Hudson, NY) were fasted for 12–16 hours
prior to infection, and housed separately from mock-infected
control mice.
16-Week Experiment
Hematology and IgG enzyme-linked immunosorbent
assay (ELISA). Blood (50–150 mL) was collected bi-weekly
by retro-orbital method into Microvette K2-EDTA tubes
(Sarstedt, Inc; Newton, NC) for CBC using a Hemavet
HV950FS analyzer (Drew Scientific; Waterbury, CT).
Simultaneously, serum was collected from one mock-infected
control and five infected mice for IgG to Salmonella O-Antigen
a n a l y s i s .F o l l o w i n ge u t h a n a s i a ,w h o l es p l e e n ,l i v e r ,a n dM L N
were weighed, homogenized and plated for bacterial CFU.
Serum IgG to Salmonella O-Antigen, measured by anti-Salmonella
IgG ELISA included an overnight culture of S.T y p h i m u r i u m
that was pelleted, washed with PBS, weighed and sonicated in
PBS. Supernatant was harvested after one hour centrifugation at
4,000 g and diluted to 100 ng of bacteria per 100 mL. 100 mLo f
lysate was incubated overnight in 96-well ELISA plates (Nunc;
Rochester, NY). Coated wells were washed and blocked (PBS
with 0.05% Tween, 1% Bovine Serum Albumin) for one hr at
37uC. Sera were diluted serially in blocking buffer, incubated in
blocked wells for two hours at room temperature, then washed.
Anti-mouse IgG antibody conjugated to horseradish peroxidase
(HRP) (Abcam ab6728-1; Cambridge, MA) was added (1:4000),
incubated for two hours at room temperature, washed and
incubated with HRP substrate according to instructions (Pierce
Protein Research Products, Rockf o r d ,I L ) .A b s o r b a n c ew a sr e a d
at 450 nm with a plate reader. Serum titer was determined from
the highest dilution of serum to give an optical density above pre-
immune serum background.
10-Week Experiment
Body temperature and blood collection. The submandi-
bular vascular bundle collection method replaced retro-orbital
bleeding to minimize distress to the animal and allow for greater
collection volume [60]. Approximately 300 mL of blood was
collected into Microtainer K2-EDTA and serum tubes (BD;
Franklin Lakes, NJ) for hematology and serum analyses at a single
time-point in mice which were then euthanized at one, three, six
and ten weeks post-infection. Blood kept at room temperature was
analyzed within four hours of collection for all parameters except
ferritin, which was frozen for later analysis. Compete blood counts
were performed using mouse specific instrumentation on an
ADVIA 120 hematology analyzer with Multispecies software
(version 3.1.8.0-MS) (Bayer Corporation, Tarrytown, NY). Serum
iron was measured with an Hitachi 917 analyzer (Roche
Diagnostics, Indianapolis, IN). Plasma fibrinogen was measured
by heat precipitation method. Fresh blood smears were Wright-
stained, and manual leukocyte differential counts were performed
to address increased percentages of large unstained cells (LUC)
measured by the Advia 120 in seventeen of twenty infected mice
(range 2.0–6.0%) compared to mock-infected controls (mean
1.0%). The majority of LUC (1–4%) were activated monocytes,
the remainder were large lymphocytes; automated monocyte
counts were corrected accordingly. Neurological signs and body
temperatures were recorded at the same time daily, and body
weights weekly. Five temperature measurements per mouse were
made daily by digital infrared thermometer (MT-100; Micro
Temp, Troy, MI) as previously described [61]. Mean difference
between infected and mock-infected mice for each day was
computed and tested in a one-sided paired t test to establish
whether the difference was greater than zero. P,0.05 was
considered significant (GAUSS Mathematical & Statistical
System Version 8.0; Aptech Systems, Inc.; Black Diamond, WA).
Cyto- and histopathology. Following euthanasia whole
spleen and liver were weighed; a section of each was weighed,
homogenized and plated for bacterial CFU. No CFU were found
in any mock-infected animals. Remaining liver and spleen, and
one femur were collected into 10% neutral buffered formalin for
histological evaluation. Bone marrow brush smear preparations
were made immediately post-mortem from the second femur,
and Wright-stained for cytological examination. Tissues were
processed by routine histological methods; paraffin sections were
stained with hematoxylin and eosin (H & E), Perl’s Prussian blue
for ferric iron (hemosiderin), and Masson’s trichrome stain for
fibrosis [62]. Intensity of iron tissue staining was subjectively
scored on a scale of 0 – 4+ by light microscopy. Photomicro-
graphs were taken with an Olympus BX50 (Olympus Cor-
poration, Center Valley, PA) using NIS-Elements package F3.0
Nikon Laboratory Imaging software (Nikon Corporation, Tokyo,
Japan).
Serum ferritin ELISA. Ferritin was quantified using a com-
mercially available mouse ELISA kit (E-90F, Immunology Con-
sultants Laboratory, Inc; Newberg, OR). Absorbance at 450 nm
was determined with a plate reader; ferritin concentrations were
calculated based on standard curves developed within the same
plate and corrected for sample dilution. To verify findings, serum
ferritin was measured in duplicated infection experiments using an
additional 10 S. Typhimurium-infected and three mock-infected
control mice at three weeks post-infection.
Flow cytometry and cell sorting. Spleens from mice
collected three weeks after S. Typhimurium infection were
mechanically homogenized and passed through a 70 mm cell
strainer (BD Biosciences, San Jose, CA) to obtain single cell
suspensions. Non-nucleated erythrocytes were lysed in hypotonic
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EDTA. Non-lysed cells were passed through a 40 mm cell strainer
and re-suspended in staining buffer (PBS +1% FBS and 0.02%
sodium azide) containing anti-mouse CD16/32 (eBioscience, San
Diego, CA) to block Fc receptors. For analysis of erythroblasts,
cells were then stained with allophycocyanin-conjugated anti-
mouse TER119 antibody [40] (BD Biosciences, San Jose, CA),
followed by staining for DNA in 10 mg/mL DAPI (Invitrogen,
Carlsbad, CA). Fluorescently labeled cells were quantified using a
CyAn ADP flow cytometer (Beckman Coulter, Fulleton, CA) and
analyzed using FlowJo software (Tree Star, Inc., Ashland, Or).
For hemophagocytic macrophage sorting, cells were stained
with phycoerythrin-conjugated anti-mouse CD11b and fluo-
rescein isothiocyanate-conjugated anti-mouse GR1 antibodies
(eBioscience, San Diego, CA). Splenocytes were fixed in 1%
paraformaldehyde/1% sucrose and permeabilized in 0.1%
saponin, then stained intracellularly for erythrocytes with allo-
phycocyanin-conjugated anti-mouse TER119 antibody, followed
by staining for DNA in 10 mg/ml DAPI. Cells were passed
through another 40 mm cell strainer, then sorted for CD11b
high,
GR1
low macrophages with at least 6N DNA content using a
MoFLoXDP cell sorter (Beckman Coulter, Fullerton, CA), and
cytospun onto poly-L-lysine coated slides (Wescor, Logan, UT) for
microscopic analysis. Confocal fluorescent micrographs were
captured using a Yokogawa CSU10 spinning disk confocal
(Tokyo, Japan) on a Nikon Eclipse TE2000-U inverted micro-
scope (Tokyo, Japan) with a 1006 Plan Apo numerical aperture
1.4 objective lens, and acquired with a Cascade II:512 (Photo-
metrics, Tucson, AZ) camera using MetaMorph 7.0 software
(Molecular Devices, Sunnyvale, CA).
Statistics. Mann-Whitney U Test and Student’s t-Test were
performed and considered significant at P,0.05. Results from
both tests were similar; only t-Test results are shown.
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